World Mitochondrial Disease Week 2026: Putting Mito on the Map
We’re delighted to announce the launch of this year’s World Mitochondrial Disease Week theme: “Putting Mito on the Map.” Members asked […]
Uncategorized
European Rare Disease Conference Calls for Stronger Cooperation Across Member States
On 3–4 June 2026, the 13th edition of the European Conference on Rare Diseases and Orphan Products took place in
Uncategorized
Global Mito Map Privacy Notice
Last updated: 19th June 2026 Who We Are The International Mito Patients (IMP) operates the Global Mito Map as part
The role of amino acids in some forms of mito
On May 9, 2026, International Mito Patients was represented at the Cognate Amino Acid for tRNA Synthetase Disorders Consortium meeting
IMP Welcomes New Members from China, Spain and US
We are delighted to announce that three additional mitochondrial organisations have joined IMP, further strengthening our global network and amplifying
IMP Welcomes FDA Approval of First-Ever Treatment for TK2d
IMP Welcomes FDA Approval of First-Ever Treatment for TK2d International Mito Patient (IMP) is delighted to welcome yesterday’s approval by
IMP Launches New TK2d Video
IMP Launches New TK2d Video To mark TK2d Awareness Day 2025, we’ve released a new video that amplifyies the voices
Scientists provide first evidence that the drug sildenafil may benefit patients with Leigh syndrome, and particularly those carrying mutations in the mitochondrial gene MT-ATP6.